AI Intelligence

Replit’s Amjad Masad on the Cursor deal, fighting Apple, and why he’d rather not sell

Source: TechCrunch AI · Category: AI Products & Releases

Replit CEO Amjad Masad discussed competitive pressure as rival Cursor reportedly negotiates acquisition by SpaceX for $60 billion valuation. Reflects intense M&A and consolidation in AI coding tools. For firms evaluating AI development platforms, this signals rapid market maturation and suggests locking in vendor agreements now; vendor stability and acquisition risk should factor into tool selection.

→ Read the full article

AI Cartoon ‘Critterz’ Misses Cannes Debut After OpenAI Shut Sora

Source: Bloomberg Technology · Category: AI Products & Releases OpenAI shut down Sora, its video-generation tool, forcing the AI film 'Critterz' to miss Cannes. This signals OpenAI is restricting or sunsetting capabilities—potentially due to safety, copyright, or commercial strategy. Track Sora's future: clients investing in AI

Google I/O showed how the path for AI-driven science is shifting

Source: MIT Technology Review AI · Category: AI Research & Breakthroughs Demis Hassabis at Google I/O proclaimed AI is 'standing in the foothills of the singularity,' signaling DeepMind's framing of near-term AI science breakthroughs as steps toward transformative capability. This is rhetorical positioning ahead of major

Kawasaki Heavy Shares Rally on AI Tie-Up Plan With Nvidia

Source: Bloomberg Technology · Category: Enterprise AI Adoption Kawasaki Heavy Industries is partnering with Nvidia on physical AI robots, triggering a 12% stock rally. This demonstrates enterprise momentum in embodied AI and robotics. For clients in manufacturing, logistics, or field services, this validates the case for pilot programs in robotic process

Insilico on Applying AI to Transform Drug Discovery

Source: Bloomberg Technology · Category: AI Use Cases & Ideas Insilico Medicine is applying AI to drug discovery and longevity research. This is a concrete application of AI to high-stakes, regulated R&D. Your pharma and biotech clients facing discovery timelines and cost pressures could pilot similar AI-augmented workflows—consider

Read more

AI Cartoon ‘Critterz’ Misses Cannes Debut After OpenAI Shut Sora

Google I/O showed how the path for AI-driven science is shifting

Kawasaki Heavy Shares Rally on AI Tie-Up Plan With Nvidia

Insilico on Applying AI to Transform Drug Discovery